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INTRODUCTION
 Gestational diabetes mellitus (GDM) is defined 
as glucose intolerance that first occurs or is first 
identified during pregnancy.1 Although the 
true prevalence of GDM is unknown, a 16–27% 
prevalence is reported worldwide,2 whereas, 8% 
pregnant females suffer from GDM in Pakistan.3-5 
GDM not only increases the likelihood of several 
maternal and perinatal complications including 
delivery by cesarean section, neonatal hypoglycemia 
and adiposity, but women with GDM and their 
offspring are also at an increased risk of developing 
diabetes later in life.5 GDM has many etiological 
factors and till date a particular pathophysiological 
mechanism singularly responsible is unidentified. 
The genome wide association studies have 
identified various susceptibility genes, including 
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ABSTRACT
Background and Objective: Genetic studies on gestational diabetes (GDM) are relatively scarce; moreover, 
limited data is available for KCNQ1 polymorphism in Pakistani pregnant women. We aimed to determine 
the frequency of KCNQ1 rs2237895 in GDM and normal pregnant controls and its association with GDM-
related phenotypes. 
Methods: A total of 637 pregnant females (429 controls and 208 cases) in their second trimester were 
classified according to the International Association of the Diabetes and Pregnancy Study criteria in 
this study. Their blood samples were genotyped for KCNQ1 SNP rs2237895 using PCR-RFLP method and 
sequencing. Fasting and two hour-post glucose load blood levels, serum HbA1c, insulin, and anthropometric 
assessment was performed. Pearson’s Chi Square test, Mann- Whitney U test, and regression analyses were 
performed. A p-value of <0.05 was considered significant.
Results: The variant genotyped was in Hardy-Weinberg equilibrium (p>0.05). The rs2237895 showed an 
association with GDM (OR 2.281; 1.388-3.746: p <0.001) and remained significant after multiple adjustments 
for age and body mass index (OR 2.068; 1.430-2.997: p=0.005). The C allele showed positive association 
with insulin level, and HOMA-IR in study subjects.
Conclusions: This study identifies that KCNQ1 rs2237895 polymorphisms might be associated with risk of 
GDM in Pakistani population and that it is related to higher glucose levels and insulin resistance. Further 
large scale studies are required to consolidate on the functional aspect of this polymorphism.
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several type 2 diabetes mellitus (T2DM) such as 
PPARG, TCF7L2, FTO, CDKN2A/2B, and IRS1 etc. 
to be associated with the risk of T2DM, though their 
definite relation with GDM remains to be explored 
further.6,7
 Recently, KCNQ1 (potassium voltage gated 
channel, KQT-like subfamily, member1) was added 
to the candidate genes conferring susceptibility to 
T2DM.8 KCNQ1 is located at chromosome 11p15.5, 
and encodes the pore-forming potassium (K+) 
channel alpha-subunit. It is expressed in the heart, 
inner ear, stomach, small and large intestine, liver, 
kidney, adipose tissue and the pancreas. So far its 
role is well researched in the pathogenesis of long 
QT syndrome and atrial fibrillation,9 where it is 
responsible for encoding a voltage-gated potassium 
channel required for the repolarization phase of the 
cardiac action potential.10 
 Insulin release from beta cells (ß) of pancreases 
is controlled by intricate interaction between 
ATP-sensitive potassium (KATP) channels, 
voltage-dependent potassium (Kv) channels and 
voltage-dependent calcium channels.11,12 KCNQ1 
is responsible for membrane repolarization of 
pancreatic ß cell, leading to cessation of calcium 
influx and subsequently insulin secretion. 
Mutations in this channel may be responsible for 
premature termination of calcium influx which 
leads to decreased insulin secretion in patients with 
T2DM and GDM.11,12
 A strong association between KCNQ1 
polymorphisms and T2DM is reported both in 
the East Asian and European populations.13,14 
The single-nucleotide polymorphisms (SNPs) 
reported has the second largest effect size next to 
TCF7L2. The following SNP (rs2237897, rs2283228, 
rs2237895, rs2074196 and rs2237892) of this gene 
have recently been shown to confer susceptibility to 
T2DM. In addition, the risk allele of rs2237892 was 
associated with impaired insulin secretion, which 
may be intermediated through an effect on beta 
cell function,15,16 whereas the C alleles of rs2237892 
and rs2237895 were found to be associated with 
increased risk of GDM in Korean population.17
 Besides these favorable results, uncertainty exists 
about their association with GDM or its related 
phenotypes. Thus, we aimed to investigate the 
association of common genetic polymorphism 
of KCNQ1 rs2237895 in gestational diabetic and 
normal pregnant controls. In addition, this SNP 
was examined for its possible association with 
GDM-related clinical phenotypes.
METHODS
 Late second trimester pregnant women from the 
antenatal care clinics of Aga Khan University and 
Abassi Shaheed Hospital in Karachi, Pakistan were 
enrolled in this case-control study. The investigation 
was carried out between February 2014 and 
February 2016. The institutional ethics committee 
approved the research protocol; written informed 
consent was obtained from all participants. 
 A total of 637 pregnant females were recruited 
by employing convenience random sampling 
technique for this case-control study. This sample 
size was considered sufficient to achieve 80% 
power and detect an odds ratio of at least 2 among 
GDM women. The two sided level of significance 
was set at 5% as calculated by NCSS/PASS version 
11 software for power analysis and sample size.18 
The study group included 208 pregnant women 
diagnosed with gestational diabetes (GDM case) 
according to the Glucose Tolerance Test (GTT) 
criteria proposed by the International Association 
of Diabetes and Pregnancy Study Group (IADPSG) 
i.e. a fasting glucose ≥92 mg/dL and/or 1 h: ≥180 
mg/dL (10.0 mmol/L) and/or 2 h: ≥153 mg/
dL (8.5 mmol/L) (when any of the following 
plasma glucose values are exceeded, the subject 
is considered as having GDM). The control group 
included 429 normo-glycemic pregnant women, 
with blood glucose levels below the above 
mentioned criteria. All study subjects (whether 
case or control) were excluded if they had diabetes 
before pregnancy or developed diabetes before 24 
weeks of gestation, impaired fasting glucose or 
impaired glucose tolerance, history of hypertension, 
twin pregnancies, taking hormonal support or any 
condition affecting the maternal fetal health. 
 The weight at booking and anthropometric 
measurements of all participants was recorded 
from the patient record cards, while current weight 
of subjects was measured in kilogram on a digital 
weighing scale in light clothing without shoes (with 
an accuracy of ±100g) while body mass index (BMI) 
was calculated. 
 Ten ml of venous blood was collected. Serum was 
obtained after centrifugation of blood samples and 
was immediately frozen at -80 C till further analyzed. 
Serum Insulin was measured using commercially 
available ELISA assay (cat# KAP1251, DIA source 
Immuno Assay S.A., Belgium), while insulin 
resistance (HOMA-IR= Glucose (mg/dl) X Insulin 
(µIU/ml)/405) and insulin sensitivity (QUICKI =1/
Log (fasting insulin μIU/ml) + log (fasting glucose 
mg/dl) were calculated. 
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 DNA was extracted from whole blood as 
per the vendor’s instruction by commercially 
available Qiagen DNA extraction kit (Cat. number 
51185, Valencia, CA, USA). The quantification of 
extracted DNA was performed by measuring the 
UV absorbance of the samples using a Nanodrop-
ND1000 (Thermo Fisher Scientific, Waltham, MA). 
A ratio of ~1.8 was considered acceptable for 
confirming the purity of extracted DNA.
 Primers were designed using NCBI primer 
designing tool for KCNQ1 rs2237895 (Forward 
CTCAGCCTGCAGTGTCCAGG; Reverse AAGG-
GACAGAGCTGCTCCCAA). Polymerase chain 
reaction (PCR) was performed using the Ruby Taq 
PCR Master mix 2X (cat# 71191, Affymetrix, USA) 
as per the manufacturer’s instructions. The ampli-
cons were digested with restriction enzyme SmaI 
(Cat #R0141L, New England Biolabs, USA) accord-
Fig.1 (A-C): Gel Electrophoresis and Sequencing Chromatogram of KCNQ1 SNPs. Where M is the 50bp DNA marker and 
B are negative controls in the PCR reaction. A: PCR amplification shown as bands on 2% agarose gel for rs2237895 (218bp) 
samples numbered 1-4. B: RFLP fragment [3 homozygous mutated: 140bp/78bp (C/C) for samples number 1, 3 & 4; 1 
heterozygous carrier: 218bp/140bp/78bp (A/C)] for sample numbered 2 respectively. C: Sequencing Chromatograms 
showing the mutations as dot and highlighted section in the aligned sequence.
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ing to the standard instructions of the manufactur-
er. The digested fragments were electrophoresed in 
2% Agarose gel.
 Genotypes were scored by an independent per-
son, who was blinded about the case control status 
of the study subjects. In the additive model, geno-
type of non-risk allele homozygote (C/C), heterozy-
gote (A/C) and risk allele homozygote (A/A) were 
coded as 0, 1 and 2 respectively. Further, negative 
controls were placed in duplicates in each run, to 
ensure correct genotyping. Overall call rate for gen-
otype data was >97%. A genotyping quality control 
was performed in 50% of the samples by duplicate 
checking (rate of concordance in duplicates was 
>99%). Further reconfirmations of genotyping accu-
racy were made by sequencing 20% of the samples 
with detected polymorphic variants (discrepancy 
rate was <0.20%) (ABI3730XL, automated DNA se-
quencer, Macrogen, Korea) (Fig.1).
Statistical Analysis: Statistical analyses were 
conducted using the IBM Statistical Package for the 
Social Sciences (IBM SPSS version 21; IBM Corp Inc, 
Armonk, NY). Descriptive analysis of categorical 
data was presented in terms of frequencies and 
percentages whereas that for continuous variables 
was expressed as mean ± standard deviation. Mann 
Whitney U test and Pearson chi-square test of 
independence were used for comparing continuous 
and categorical variables wherever applicable. 
Hardy–Weinberg equilibrium (HWE) was 
calculated for SNP data. SNP data was analysed 
for genotype and allele frequency determination by 
applying chi-squared statistics. Significance of risk 
allele with study parameters was determined with 
regression analyses. Genotypes were allotted code 
of 0/1/2 rendering the number of minor alleles 
under an additive model of inheritance.
RESULTS
 Six hundred and thirty-seven pregnant females 
were recruited in this study. The GDM group had 
a higher BMI, pre and post load GTT, HBA1c and 
insulin levels (p<0.01) when compared to pregnant 
controls (Table-I).
 Genotype and allele frequencies of the study 
subjects are given in Table-II. The genotyped variant 
showed a strong association with GDM (p<0.001). 
The rs2237895 C allele depicted a significant risk 
association with GDM (p<0.001).
 Further, regression analysis was performed on 
unadjusted genotypes and after adjusting with 
risk factors such as age and pre pregnancy BMI. A 
significant association was observed with GDM (OR 
2.281; p = 0.0002), which remained independently 
linked with GDM risk (OR 2.068; p=0.005) even 
after multiple comparison under additive model 
(Table-III).
 We also investigated the association of KCNQ1 
variant with quantitative traits associated with 
obesity and glucose homeostasis in the study 
cohort. Linear regression analysis revealed a 
moderately significant association of ‘C’ allele with 
insulin levels (β = -0.238 p = 0.0007), HbA1c (β = 
-0.123 p< 0.001) while weak association were seen 
with HOMA-IR (β = -0.021 p< 0.001) and fasting 
blood glucose (β = -0.043 p< 0.001). 
Table-II: Genotypes and Allele Frequencies of KCNQ1 rs2237895 polymorphism.
Genotype Control (n=429) Case (n=208) P value Allele Group                          Allele Data
 rs2237895     Frequency n (%) OR (95%CI) P value
AA 175 (40.8) 51 (24.5) <0.001 C Control 320 (37.50) 1.557 (1.228-1.973)  < 0.001
AC 188 (43.8) 114 (54.8)   Case 216 (51.92)  
CC 66 (15.4) 43 (20.7)  A Control 538 (62.50)  
     Case 200 (48.08)  
Genotype AA: homozygous dominant; AC: heterozygous mutated; CC: homozygous mutated.
A is the major allele and C is the minor allele. Frequencies are given as absolute values with percentage given in 
parenthesis. The Hardy Weinberg Equilibrium (HWE) stats for the study cohort was > 0.05
P value <0.05 calculated by Pearson’s x2 square test.
Table-I: Clinical and biochemical data 
of cases and controls.
Variables Control n=429 Case n=208
 Mean ± S.D Mean ± S.D
Age (in year) 25.97 ± 4.87 27.31± 5.56
Weight at Booking (kg) 57.55 ± 10.15 63.84± 12.58**
BMI at Booking (kg/m2) 22.77 ± 4.19 24.83 ± 5.13**
GTT 0 hr (mg/dl) 78.69 ± 8.96 106.23 ± 20.70 **
GTT 2 hr (mg/dl) 124.22 ± 11.94 177.33 ± 45.57**
HbA1c (%) N.A 5.79 ± 1.43
Insulin (IU/mL) 13.28 ± 5.26 37.08 ± 7.66**
BMI (body mass index), GTT (glucose tolerance test). 
Values expressed as Mean ± SD. Groups compared by 
Mann Whitney U test for continuous data. **p<0.01
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DISCUSSION
 There are many proposed theories such as 
polymorphisms in PPAR2, IGF2BP2, CDKL1 and 
CDKN2a in the quest to find a link between genetic 
factors and GDM.7 Many studies have linked T2DM 
with polymorphisms in KCNQ1 gene.16,11,13,19 but 
few with GDM. We focused on rs2237895 SNP in 
the KCNQ1 gene which is known to be a susceptible 
T2DM candidate gene, and it showed a possible 
sound association with GDM in our study (Table 
II and III). Our findings are in line with the initial 
data on the link between KCNQ1 and GDM which 
came through studies done in Korean population. 
It was reported that the C allele of rs2237895 was 
associated with increased risk of GDM (OR=1.24; 
p=0.005).6,20,21 Similar results to our study were 
found in a Chinese population.22 We also report 
a risk allele frequency of 52% in GDM positive 
females, which is somewhat close to the risk allele 
frequency of 45% reported in Indian Punjabis with 
T2DM,13 35% in Chinese females with GDM,22 33% 
in Korean GDM females20 and 34.5% in Chinese 
subjects with T2DM.23
 Similarly, the minor allele frequency reported 
in our study was 37.5% in our control population 
(Table-II), which is close to a previously published 
result of 42%.13 The difference in frequencies reported 
could be due to a different set of ethnic population at 
a different geographic location tested. A moderately 
significant association of ‘C’ allele with insulin levels, 
HbA1c, insulin resistance and fasting glucose levels 
was observed in our study similar to a previous 
report.13 Additionally, in two recent related studies 
for Pakistani population it was reported that SNPs 
in or near PPARG, TCF7L2, FTO, CDKN2A/2B, 
and KCNQ1 may have potential associations with 
T2DM, with similar effect sizes to those seen in 
European populations.6,24 Though, this is an exciting 
finding further research is required to establish an 
affirmative causal link.
 We also observed that both weight and body mass 
index (BMI) values were higher in our GDM cases 
in comparison to controls (Table-I). Asian’s are 
known to have a higher body fat proportion even at 
a lower BMI value in comparison to Caucasian’s,26 
and this situation might lead to early development 
of adverse effects during pregnancy. Though, we 
failed to identify any significant association in 
terms of weight and BMI with the minor allele in 
our study population. Despite the fact that weight 
of the baby is controlled by the anthropometric 
measures of the parents’ via genetic bond, mother’s 
weight has a supplementary effect, controlling 
the intrauterine environment. This suggests that 
KCNQ1 polymorphism may not have a direct 
impact on the weight status of an individual but act 
by other pathways to induce insulin resistance in 
GDM and/or T2DM. 
 The associations between KCNQ1 polymorphisms 
and increased risk for GDM not only indicate 
similar pathogenic mechanisms with T2DM but 
also make KCNQ1 a novel potential therapeutic 
target for both T2DM and GDM. Our study was 
limited in a way that we were unable to recruit 
large number of study participants due to cultural 
constraints about genetic studies. More so, we did 
not focus on the lifestyle factors or environmental 
factors, such as diet and physical activities, which 
prevents us from analysing any interaction between 
rs2237895 and other factors on GDM. Nevertheless, 
the rs2237895 polymorphism was in HWE in the 
both groups, suggesting the randomness of subject 
selection which is a strength of our study.
CONCLUSION
 This study identifies that KCNQ1 rs2237895 
polymorphisms might be associated with risk 
of GDM in Pakistani population and that it is 
related to the higher glucose levels and insulin 
resistance. Further large scale studies are required 
to consolidate on the functional aspect of this 
polymorphism.
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